TLDR:
- Terumo, a Japanese medical equipment maker, has set up a $75 million venture capital fund to invest in advanced technologies for cardiovascular treatment.
- The Terumo Ventures division was established at the Terumo Americas Holding unit in New Jersey, with plans to expand to Boston, Silicon Valley, and Belgium.
Japanese medical equipment maker Terumo has established a corporate venture capital fund with a focus on investing in advanced technologies for cardiovascular treatment. The $75 million fund, known as Terumo Ventures, was launched within the company’s subsidiary, Terumo Americas Holding, located in New Jersey. The division also plans to establish bases in Boston, Silicon Valley in California, and Belgium.
The new venture capital fund aims to invest in startups that are working on innovative treatments in the cardiovascular space, with a potential interest in mergers and acquisitions in the future. By setting up bases in key locations known for innovation and technology, Terumo is positioning itself to tap into cutting-edge advancements in the field.
This move reflects Terumo’s commitment to staying at the forefront of medical technology and ensuring that it can leverage the latest advancements to enhance its offerings in cardiovascular treatment. By investing in startups with promising technologies, Terumo is not only supporting innovation in the sector but also positioning itself for potential strategic partnerships down the line.
